Context.—Lobular carcinoma in situ (LCIS) as the primary pathologic diagnosis in a needle
core biopsy is an infrequent finding, and the management of patients in this setting is …

OBJECTIVE. The objective of our study was to show the importance of surgical excision after
the diagnosis of lobular carcinoma in situ (LCIS) based on needle core biopsy. MATERIALS …

Core needle biopsy is the preferred technique for evaluating breast masses and abnormal
mammographic findings. The frequency of detection of noninvasive lobular lesions by core …

The question of whether excisional biopsy is required following a diagnosis of atypical
lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS) at core-needle biopsy is both …

Lobular carcinoma in situ (LCIS) is considered a risk factor for development of invasive
carcinoma (IC). Many variants of LCIS have been described based on pathologic features …

Context.—The management of lobular neoplasia (LN) found on core biopsy is controversial
and ranges from obligatory surgical excision to clinical/imaging observation. Objective.—To …

Background Management of patients with classic lobular carcinoma in situ diagnosed on
core needle biopsy remains controversial, in part because of clinicopathologic overlap with …

Context.—Both atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) have
traditionally been considered to be risk factors for the development of invasive carcinoma …

AIM: To retrospectively review the surgical histological findings in all cases where lobular
carcinomain situ (LCIS) was identified on percutaneous core biopsy (CB) performed as part …

PURPOSE: To retrospectively determine frequency of invasive cancer or ductal carcinoma in
situ (DCIS) at excisional biopsy in women with atypical lobular hyperplasia (ALH) or lobular …